Rana Ghosh, PhD, second from left, of the University of Texas, Austin, is one of thousands of promising scientists whose careers have been advanced by PhRMA Foundation support.Learn how YOUR project can be funded.
Value Assessment Initiative
The PhRMA Foundation’s Value Assessment Initiative advances high-quality care in the U.S., while avoiding low value or inefficient care. The initiative funds new research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency.
Sam Emaminejad, PhD, is an Assistant Professor in the Electrical and Computer Engineering department at UCLA and the founder and director of the Interconnected & Integrated Bioelectronics Lab. His lab focuses on the development of an ecosystem of integrated wearable, mobile, and in-vivo physiological and environmental monitoring platforms to enable personalized and precision medicine. Dr. Emaminejad, who received a PhRMA Research Starter Grant in Translational Medicine and Therapeutics in 2018, has received numerous honors and awards, including a Distinguished Young Investigator Award for leading a multi-center program on remote patient monitoring with UCLA, Intermountain Healthcare and Stanford School of Medicine. He recently discussed his work in a short online video.
Utilize our site for updates and announcements or follow PhRMA Foundation on twitter @PhRMAFoundation
PhRMA Foundation Surpasses $2.8 Million in Funding for Leaders in Value Assessment
The PhRMA Foundation has announced a new cycle of awards to support transformative strategies that better assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency in health care. More than $2.8 million has been provided to date to establish four national value-assessment Centers of Excellence and support the work of several researchers focused on value-based health care. Learn more about the awards and how to apply for 2019 or 2020 funding.
Challenging Old Methodologies to Establish What Value in Health Care Really Means
For years, U.S. policy makers have struggled with the difficulties of assessing value in health care — often focusing too strongly on cost. In an article recently published in the publication Value & Outcomes Spotlight, PhRMA Foundation President Eileen Cannon discusses how researchers are challenging older methodologies to establish new ways of measurement that more accurately reflect how patients and families view value. Read the article here.
Learn More About the Foundation in our 2017 Annual Report
Over the last year, the PhRMA Foundation provided more than $3.2 million in funding to dozens of the nation’s leading young researchers, while supporting important new initiatives in areas such as Value Assessment in health care. View a copy of the the annual report here.